<p><i>Mycobacterium tuberculosis</i> (<i>Mtb</i>) persists as a global health threat partly by establishing long-term reservoirs in myeloid cells. Although progenitors have been proposed as additional sites of persistence and immune reprogramming, it remains unclear whether circulating human hematopoietic stem/progenitor cells (HSPC) are permissive to <i>Mtb</i> infection. Here, we show that peripheral blood-derived CD34<sup>+</sup> HSPC are permissive to <i>Mtb</i>, in vitro. Confocal microscopy showed <i>Mtb</i> cytoplasmic localization, while colony-forming unit (CFU) quantification demonstrated early intracellular <i>Mtb</i> growth. Flow cytometry revealed preferential <i>Mtb</i> infection of multipotent progenitors (MPP) with progressive enrichment of granulocyte-monocyte progenitors (GMP) and lineage-committed cells, indicating myeloid skewing. Infection drove early IL-8 and TNF-α release, followed by MIP-1α, MIP-1β, and IP-10, demonstrating a dynamic inflammatory response by CD34<sup>+</sup> progenitors. Parallel infection experiments with <i>Mycobacterium bovis</i> BCG revealed that, despite lacking key virulence determinants, BCG infects CD34<sup>+</sup> cells in vitro with a preference for MPP. Unlike <i>Mtb</i>, BCG infection did not promote expansion of more differentiated progenitor subsets, indicating that virulence-dependent mechanisms are required to drive progenitor differentiation and myeloid skewing. These findings identify CD34<sup>+</sup> HSPC as a permissive niche for mycobacterial infection and suggest that <i>Mtb</i>-specific virulence factors contribute to the modulation of progenitor differentiation. Further studies are needed to fully assess the consequences of these events on the systemic immune modulation observed during tuberculosis infection.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Mycobacterium tuberculosis infects human peripheral hematopoietic multipotent progenitors and promotes their myeloid differentiation in vitro

  • Tonino Alonzi,
  • Daniela Peruzzu,
  • Alessandra Aiello,
  • Giulio Bontempi,
  • Chiara Farroni,
  • Federica Repele,
  • Settimia Sbarra,
  • Valentina Vanini,
  • Ivana Palucci,
  • Michela Sali,
  • Luca Pierelli,
  • Raffaele Strippoli,
  • Giovanni Delogu,
  • Delia Goletti

摘要

Mycobacterium tuberculosis (Mtb) persists as a global health threat partly by establishing long-term reservoirs in myeloid cells. Although progenitors have been proposed as additional sites of persistence and immune reprogramming, it remains unclear whether circulating human hematopoietic stem/progenitor cells (HSPC) are permissive to Mtb infection. Here, we show that peripheral blood-derived CD34+ HSPC are permissive to Mtb, in vitro. Confocal microscopy showed Mtb cytoplasmic localization, while colony-forming unit (CFU) quantification demonstrated early intracellular Mtb growth. Flow cytometry revealed preferential Mtb infection of multipotent progenitors (MPP) with progressive enrichment of granulocyte-monocyte progenitors (GMP) and lineage-committed cells, indicating myeloid skewing. Infection drove early IL-8 and TNF-α release, followed by MIP-1α, MIP-1β, and IP-10, demonstrating a dynamic inflammatory response by CD34+ progenitors. Parallel infection experiments with Mycobacterium bovis BCG revealed that, despite lacking key virulence determinants, BCG infects CD34+ cells in vitro with a preference for MPP. Unlike Mtb, BCG infection did not promote expansion of more differentiated progenitor subsets, indicating that virulence-dependent mechanisms are required to drive progenitor differentiation and myeloid skewing. These findings identify CD34+ HSPC as a permissive niche for mycobacterial infection and suggest that Mtb-specific virulence factors contribute to the modulation of progenitor differentiation. Further studies are needed to fully assess the consequences of these events on the systemic immune modulation observed during tuberculosis infection.